What does APOTHEEK JOCHMANS do?

APOTHEEK JOCHMANS is a pharmacy in Jette. Private Limited, started on 25 September 1996, 1 establishment.

What is the address of APOTHEEK JOCHMANS?

The registered office of APOTHEEK JOCHMANS is located at Jetse Laan 290, 1090 Jette.

Is APOTHEEK JOCHMANS still active?

Yes. According to the CBE (30 October 2026) APOTHEEK JOCHMANS is active, legal situation “Normale toestand”, started on 25 September 1996.

Is APOTHEEK JOCHMANS registered on Peppol?

Yes, APOTHEEK JOCHMANS is registered on the Peppol network with ID 0208:0458875524.

What is the enterprise number of APOTHEEK JOCHMANS?

The enterprise number of APOTHEEK JOCHMANS is BE0458875524.

When was APOTHEEK JOCHMANS founded?

APOTHEEK JOCHMANS was founded on 25 September 1996.

Who are the directors of APOTHEEK JOCHMANS?

According to the 2025 annual accounts, the directors of APOTHEEK JOCHMANS are: S.P.S. NV.

Is APOTHEEK JOCHMANS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 September 1996; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK JOCHMANS make in 2025?

APOTHEEK JOCHMANS posted a profit after taxes of € 37,082 in financial year 2025.

What is the revenue of APOTHEEK JOCHMANS?

As a small company, APOTHEEK JOCHMANS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 73,228.

APOTHEEK JOCHMANS (Private Limited) - Jette

Dossier APOTHEEK JOCHMANS, printed on 30 October 2026 from databakkes.be/en/0458875524/apotheek-jochmans. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Tight liquidity NBB

Cash and receivables cover 10 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

APOTHEEK JOCHMANS from Jette, company number BE0458875524, closed financial year 2025 with a result of € 37,082 after tax. For that financial year APOTHEEK JOCHMANS recorded a gross margin of € 73,228 and equity of € -1 million. Compared with financial year 2024, the result moved from € 72,312 to € 37,082. The company is profitable. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Caution

€ -1 million

▲ € 37,082 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 37,082

▼ 49% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 37,033

▲ 144% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -1 million.

People and assets in 2025

Wage cost

€ 1,308

▼ 14% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 622

▼ 38% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 13 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 334,258

▼ 7% vs 2024

€ 26,478 is repaid this year. At this pace the long-term loan is gone in ≈ 13 years.

Owed to suppliers

€ 42,824

▼ 22% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 153,885 Gross margin 2022: € 153,885 First fiscal year in the series	€ 129,301 Gross margin 2023: € 129,301 ▼ 16% vs 2022 (€ 153,885) Unfavourable step	€ 108,604 Gross margin 2024: € 108,604 ▼ 16% vs 2023 (€ 129,301) Unfavourable step	€ 73,228 Gross margin 2025: € 73,228 ▼ 33% vs 2024 (€ 108,604) Unfavourable step	▼ 33%
Profit after taxes	€ 131,646 Profit after taxes 2022: € 131,646 First fiscal year in the series	€ 93,624 Profit after taxes 2023: € 93,624 ▼ 29% vs 2022 (€ 131,646) Unfavourable step	€ 72,312 Profit after taxes 2024: € 72,312 ▼ 23% vs 2023 (€ 93,624) Unfavourable step	€ 37,082 Profit after taxes 2025: € 37,082 ▼ 49% vs 2024 (€ 72,312) Unfavourable step	▼ 49%
Equity	€ -1,235,094 Equity 2022: € -1,235,094 First fiscal year in the series	€ -1,141,470 Equity 2023: € -1,141,470 ▲ € 93,624 vs 2022 (€ -1,235,094) Favourable step	€ -1,069,158 Equity 2024: € -1,069,158 ▲ € 72,312 vs 2023 (€ -1,141,470) Favourable step	€ -1,032,076 Equity 2025: € -1,032,076 ▲ € 37,082 vs 2024 (€ -1,069,158) Favourable step	▲ € 37,082
Total debts	€ 1,962,875 Total debts 2022: € 1,962,875 First fiscal year in the series	€ 1,883,860 Total debts 2023: € 1,883,860 ▼ 4% vs 2022 (€ 1,962,875) Favourable step	€ 1,758,546 Total debts 2024: € 1,758,546 ▼ 7% vs 2023 (€ 1,883,860) Favourable step	€ 1,718,321 Total debts 2025: € 1,718,321 ▼ 2% vs 2024 (€ 1,758,546) Favourable step	▼ 2%
Cash	€ 36,642 Cash 2022: € 36,642 First fiscal year in the series	€ 53,727 Cash 2023: € 53,727 ▲ 47% vs 2022 (€ 36,642) Favourable step	€ 15,189 Cash 2024: € 15,189 ▼ 72% vs 2023 (€ 53,727) Unfavourable step	€ 37,033 Cash 2025: € 37,033 ▲ 144% vs 2024 (€ 15,189) Favourable step	▲ 144%
Land & buildings	€ 537,886 Land & buildings 2022: € 537,886 First fiscal year in the series	€ 521,318 Land & buildings 2023: € 521,318 ▼ 3% vs 2022 (€ 537,886) Unchanged	€ 504,751 Land & buildings 2024: € 504,751 ▼ 3% vs 2023 (€ 521,318) Unchanged	€ 488,379 Land & buildings 2025: € 488,379 ▼ 3% vs 2024 (€ 504,751) Unchanged	▼ 3%
Retained profit	€ -1,247,494 Retained profit 2022: € -1,247,494 First fiscal year in the series	€ -1,153,870 Retained profit 2023: € -1,153,870 ▲ € 93,624 vs 2022 (€ -1,247,494) Favourable step	€ -1,081,558 Retained profit 2024: € -1,081,558 ▲ € 72,312 vs 2023 (€ -1,153,870) Favourable step	€ -1,044,476 Retained profit 2025: € -1,044,476 ▲ € 37,082 vs 2024 (€ -1,081,558) Favourable step	▲ € 37,082
Bank debt	€ 410,957 Bank debt 2022: € 410,957 First fiscal year in the series	€ 385,830 Bank debt 2023: € 385,830 ▼ 6% vs 2022 (€ 410,957) Favourable step	€ 360,278 Bank debt 2024: € 360,278 ▼ 7% vs 2023 (€ 385,830) Favourable step	€ 334,258 Bank debt 2025: € 334,258 ▼ 7% vs 2024 (€ 360,278) Favourable step	▼ 7%
Balance sheet total	€ 727,781 Balance sheet total 2022: € 727,781 First fiscal year in the series	€ 742,390 Balance sheet total 2023: € 742,390 ▲ 2% vs 2022 (€ 727,781) Unchanged	€ 689,388 Balance sheet total 2024: € 689,388 ▼ 7% vs 2023 (€ 742,390) Unchanged	€ 686,245 Balance sheet total 2025: € 686,245 Unchanged (€ 689,388) Unchanged

Key figures of APOTHEEK JOCHMANS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK JOCHMANS?

What happened at APOTHEEK JOCHMANS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 22, 2026 New annual accounts for financial year 2025: profit of € 37,082 (▼ 49% vs 2024). Source: NBB ↗
Dec 18, 1997 New establishment in Jette. KBO
Sep 25, 1996 Start of the company according to the CBE. KBO

In short

From € 131,646 profit in 2022 to € 37,082 profit in 2025.

Best year ever: 2022, with € 131,646 profit.

Original PDFs at the National Bank ↗

Management

S.P.S. 100%

The stake of S.P.S. comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK JOCHMANS

Behind APOTHEEK JOCHMANS is S.P.S. NV. The shares are held by S.P.S. (100%).

Directors

According to the 2025 annual accounts

S.P.S. NV

Director · represented by Prikken Ludovikus

Also active at: JUMATEX, Pharmacie des Croisades, PHARDEC, PHARMACIE BAUDUIN, PHARMACIE LA BRABANCONNE

Shareholders

S.P.S.

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Jetse Laan 290

1090 Jette

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

IMPERIUM PHARMA

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0458.875.524

VAT number

BE 0458.875.524

Registered office

Jetse Laan 290, 1090 Jette

Names & denominations

APOTHEEK JOCHMANS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

25 September 1996

Peppol

Active · Active since 26 Jun 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK JOCHMANS

Warning lights

Financials

What happened to APOTHEEK JOCHMANS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions